Healthcare & Life Sciences
AirNexis Therapeutics
San Carlos, United Statesairnexis.com/
AirNexis Therapeutics is a Healthcare & Life Sciences startup based in San Carlos, the United States, most recent round Series A, 2 tracked investors.
Activeseries-a
series-a
Stage
2
Investors
About AirNexis Therapeutics
Based in San Carlos, the United States, AirNexis Therapeutics is a startup. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
AirNexis Therapeutics is developing AN01, a dual PDE3/4 inhibitor currently in Phase 2 clinical trials, targeting treatment for chronic obstructive pulmonary disease (COPD).
Explore AirNexis Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.